ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Cancer Immunology and Immunotherapy
Immuno-Oncology
Latest ESMO videos
Featured medwireNews
CheckMate 816 Shows Benefit Of Neoadjuvant Nivolumab–Chemotherapy For Operable NSCLC
Adjuvant PD-1 Inhibitor Chronic Immune-Related AEs Highlighted In Advanced Melanoma
First-Line Nivolumab–Cabozantinib Boosts Advanced RCC Outcomes
Enfortumab Vedotin Shows Promise For Cisplatin-Ineligible Advanced UC After ICI Therapy
CLEAR Benefit Found For Lenvatinib–Pembrolizumab In Advanced RCC
E-Learning
ESMO E-Learning: Immunotherapy Strategies for Colorectal Cancer
ESMO E-Learning: Next Generation Drugs in Kidney Cancer
ESMO E-Learning: New Treatments in Melanoma
ESMO E-Learning: Future Directions in Clinical Research of NSCLC
Factsheets on Biomarkers
Tumour Mutational Load: ESMO Biomarker Factsheet
Meeting resources
ESMO Course
ESMO Virtual Preceptorship on Immuno-Oncology December 2020
Virtual
ESMO Congress
ESMO Immuno-Oncology Virtual Congress 2020
Virtual
ESMO Course
ESMO Virtual Preceptorship on Immuno-Oncology 2020
Virtual
ESMO Congress
ESMO Asia Virtual Congress 2020
Virtual